Fact sheet 2008
Chairman and CEO | Daniel Vasella, M.D. |
Headquarters | Basel, Switzerland |
Major R&D sites | Basel, Switzerland |
Cambridge, Massachusetts | |
East Hanover, New Jersey | |
Horsham, England | |
Shanghai, China |
Major production sites | Basel, Switzerland |
Grimsby, England | |
Huningue, France | |
Kundl, Austria | |
Kurtkoy, Turkey | |
Lincoln, Nebraska | |
Ringaskiddy, Ireland | |
Schaftenau, Austria | |
Schweizerhalle, Switzerland | |
Singapore | |
Stein, Switzerland | |
Suffern, New York |
Web site address | www.novartis.com |
Stock exchange listings | SIX Swiss Exchange, traded on SWX Europe (NOVN.VX) |
New York Stock Exchange (NVS) |
2008 net sales | USD 41.5 billion |
![](https://webarchive.library.unt.edu/web/20091012030927im_/http://www.novartis.com/images/newsroom/net-sales.jpg)
2008 R&D spending | USD 7.2 billion |
![](https://webarchive.library.unt.edu/web/20091012030927im_/http://www.novartis.com/images/newsroom/rd-spending.jpg)
2008 full-time associates | total 96 717 |
![](https://webarchive.library.unt.edu/web/20091012030927im_/http://www.novartis.com/images/newsroom/full-time-associates.jpg)
Get Novartis Media Releases through RSS
Stay Connected
Receive updates on company news and announcements.